Irinotecan in Treating Patients With Recurrent Glioma

NCT00003134 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: irinotecan hydrochloride

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]